Akebia Therapeutics Vs. Eli Lilly and Industry Stock Comparison

Sell

36

AKBA
Akebia Therapeutics

Last Price:

1.37

Seasonality Move:

-2.71%

Sell

48

LLY
Eli Lilly and

Last Price:

921.81

Seasonality Move:

4.48%

Sell

36

Akebia Therapeutics (AKBA) is a Sell

Is Akebia Therapeutics a Buy, Sell or Hold?

The current Akebia Therapeutics [AKBA] share price is $1.37. The Score for AKBA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
AKBA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

48

Eli Lilly and (LLY) is a Sell

Is Eli Lilly and a Buy, Sell or Hold?

The current Eli Lilly and [LLY] share price is $921.49. The Score for LLY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
LLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

The Akebia Therapeutics share price today is $1.37
The current trend is moderately bearish and AKBA is experiencing slight buying pressure.

LLY Stock Price Chart

What is Eli Lilly and's stock price today?

The Eli Lilly and share price today is $921.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing slight selling pressure.

AKBA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0	Sell
Relative Strength Index (14 RSI):	46.8	Sell
Chaikin Money Flow:	264579	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.39 - 1.51)	Sell
Bollinger Bands (100):	(1.07 - 1.43)	Buy

LLY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	3.06	Buy
Relative Strength Index (14 RSI):	52.04	Buy
Chaikin Money Flow:	-3728715	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(911.99 - 950.85)	Sell
Bollinger Bands (100):	(803.55 - 930.61)	Buy

AKBA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.4	Sell
20-day SMA:	1.44	Sell
50-day SMA:	1.39	Sell
200-day SMA:	1.37	Buy
8-day EMA:	1.39	Sell
20-day EMA:	1.41	Sell
50-day EMA:	1.36	Buy
200-day EMA:	1.3	Buy

LLY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	918.86	Buy
20-day SMA:	929.28	Sell
50-day SMA:	894.81	Buy
200-day SMA:	781.85	Buy
8-day EMA:	917.43	Buy
20-day EMA:	918.52	Buy
50-day EMA:	901.33	Buy
200-day EMA:	788.93	Buy

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.14 per share, and an increase next year of $0.01 per share.

Eli Lilly and Earnings Growth & LLY Earnings Dates

Analysts estimate an earnings increase this quarter of $4.62 per share, an increase next quarter of $1.15 per share, an increase this year of $10.06 per share, and an increase next year of $6.23 per share.

Akebia Therapeutics Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Eli Lilly and Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):